CTNS and cancer: Although increasing evidence suggests that hs-cTns in cancer populations can predict all-cause mortality and left ventricular ejection fraction (LVEF) decline, little is known about the prediction of other systolic and diastolic functional echocardiographic parameters [10,11,12,13,14,15].